SARMs vs. Anabolic Steroids: Evidence, Risks, and Canada Status
Short answer: current evidence does not support calling selective androgen receptor modulators (SARMs) a safe or approved alternative to anabolic steroids. The two groups differ in chemistry, research history, and regulatory treatment, but both can affect androgen signalling and both carry important uncertainties. Direct head-to-head human safety trials are not available, so a simple “which is safer” ranking would overstate the evidence.
This research summary explains what is known, what remains uncertain, and how the Canadian regulatory position should shape interpretation. It does not provide dosing, cycle, or human-use guidance.
Key findings
- SARMs were designed to activate the androgen receptor with greater tissue selectivity than conventional anabolic steroids, but selectivity is not the same as proven safety.
- Health Canada states that SARMs have not been authorized in Canada for any medical use and associates them with serious safety concerns, including hormonal suppression and heart or liver disease.
- Anabolic steroids and their derivatives are regulated as controlled substances in Canada. Their adverse-effect profile is better documented because clinical and non-medical exposure has been studied for longer.
- Human SARM trials are generally short, use selected patient populations, and do not establish the long-term safety of recreational or unsupervised exposure.
- There is no reliable evidence basis for describing one class as categorically “milder” or recommending either for physique or performance goals.
How the two categories differ
| Question | SARMs | Anabolic steroids |
|---|---|---|
| Primary research concept | Selective modulation of androgen receptors, with the goal of separating some anabolic effects from effects in other tissues. | Systemic androgen-receptor activity from testosterone-related compounds and derivatives. |
| Human evidence | Compound-specific and limited. Trials often involve older adults or patients with serious disease and short follow-up. | Broader clinical and observational literature, including established therapeutic uses for some agents and extensive evidence on misuse-related harm. |
| Canadian status | Health Canada says SARMs are not authorized for any medical use in Canada. | Anabolic steroids and their derivatives are controlled under Schedule IV of the Controlled Drugs and Substances Act. |
| Can safety be generalized? | No. Findings from one SARM, dose, population, or study design cannot be transferred automatically to another. | No. Risk varies by compound, exposure, route, patient factors, and medical supervision. |
What human SARM research can and cannot tell us
A 2023 systematic review identified 33 eligible reports involving clinical trials and case reports. It found liver-enzyme elevations in trials and case reports involving drug-induced liver injury, tendon rupture, and rhabdomyolysis. These data identify safety signals, but they do not provide a complete long-term risk estimate.
A later sports-medicine systematic review also emphasized the limited quality of evidence available for athlete use, including contamination concerns and reports of liver injury, myocarditis, and tendon rupture. Clinical findings from controlled investigational products should not be assumed to describe products obtained from an unverified online supply chain.
Health Canada’s current bodybuilding-products guidance is more direct: SARMs are not authorized for medical use in Canada, and products sold online may contain a different drug than the label claims. That makes identity and documentation separate questions from the pharmacology of the named compound.
Why “safer” is the wrong conclusion
Mechanistic selectivity is a research hypothesis, not a consumer safety designation. A compound may behave selectively at one exposure or endpoint and less selectively at another. Short studies can also miss delayed, uncommon, or cumulative outcomes.
For anabolic steroids, recognized risks include cardiovascular, hepatic, endocrine, reproductive, and psychiatric effects. For SARMs, the evidence base is smaller, but smaller does not mean safer: it means the uncertainty is larger. Without direct comparative trials using defined products, comparable exposures, and adequate follow-up, a categorical safety ranking is not scientifically defensible.
Canada-specific regulatory context
Health Canada says that SARMs have not been authorized in Canada for any medical use. Authorized prescription drugs carry an eight-digit Drug Identification Number (DIN); a research-use label does not convert an unauthorized health product into an approved medicine. Anabolic steroids and their derivatives are separately regulated as controlled substances.
Regulatory status can change, and the legal treatment of a specific substance or activity may depend on facts that a general article cannot resolve. See our current RAD-140 Canada status summary for an example of how we separate authorization, control status, and research context.
How to evaluate research claims
- Confirm the compound, formulation, concentration, lot, and analytical method.
- Separate cell and animal findings from controlled human outcomes.
- Check the population: oncology, frailty, or other clinical cohorts do not represent healthy recreational users.
- Look for duration, comparator, adverse-event reporting, withdrawals, and laboratory monitoring.
- Do not treat a vendor’s “research use only” wording as evidence of regulatory approval or human safety.
For a broader evidence map, read the Complete SARMs Research Guide. For documentation standards, see how to evaluate COAs, purity, and testing records.
References
- Health Canada: Using bodybuilding products.
- Beverley et al. Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults.
- Athlete Selective Androgen Receptor Modulators Abuse: A Systematic Review.
- U.S. FDA: Safety warning on SARMs.
- Controlled Drugs and Substances Act, Schedule IV.
Research and regulatory information only. This article is not medical or legal advice and does not recommend human use.